Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Integra Lifesciences Holdings Corp Company Profile (NASDAQ:IART)

Consensus Ratings for Integra Lifesciences Holdings Corp (NASDAQ:IART) (?)
Ratings Breakdown: 3 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $67.17 (0.62% upside)

Current Analysts' Coverage Summary for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Show:
DateFirmActionRatingPrice TargetActions
5/4/2015RBC CapitalBoost Price TargetSector Perform$62.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015BarclaysBoost Price TargetEqual Weight$60.00 -> $63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015Lake Street CapitalDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2015OppenheimerBoost Price TargetOutperform$62.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015ArgusBoost Price TargetBuy$61.00 -> $72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2015Piper JaffrayInitiated CoverageOverweight$67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Jefferies GroupBoost Price TargetBuy$57.00 -> $67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2014Bank of AmericaUpgradeUnderperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2013Morgan StanleyUpgradeUnderweight -> Equal Weight$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2013 forward)